We hope to catch up with you for this virtual event and look forward to learning more!
TRANSFORMING THE PHARMA BUSINESS FOR GROWTH
As they move past the immediate challenge of contributing solutions to deal with the Covid-19 pandemic, pharmaceutical and biotech companies will face a changed world, but one in which their well-honed focus on innovation will play a vital role. Despite the many devastating impacts, the crisis represents an opportunity to innovate at a quicker pace, refine growth strategies and build new partnerships. Areas of focus considered increasingly important prior to the crisis, to include the faster uptake of technology to transform R&D, the need to strengthen the ecosystem for innovation and adopting a strategic approach to manufacturing and supply chains will assume an even more prominent role.
Entitled ‘Transforming the Pharma Business for Growth’, the conference will feature an outstanding line-up of speakers sharing their insights, ideas and expertise on topics to include the increasingly complex and uncertain political and pricing environment, re-shaping the pharma pipeline for growth and the coronavirus epidemic as a 21st century case study of pharma and health.